2. Introduction;
Up until the 1950s, strict bed rest
was thought to be the best medicine
after a heart attack. Following discharge
moderately stressful activity such as
climbing stairs was discouraged for a
year or more.
"The patient is to be guarded by day
and night nursing and helped in every
way to avoid voluntary movement or
effort."
3. Definition;
Cardiac rehabilitation has been defined as the sum of
activities required to ensure cardiac patients the best
possible physical, mental and social conditions so that
they may, by their own efforts, resume and maintain
as normal a place as possible in the community.
Cardiac rehabilitation has also been described as the
combined and coordinated use of medical,
psychosocial, educational, vocational and physical
measures to facilitate return to an active and satisfying
lifestyle.
Coordinated, multifaceted interventions designed to
optimize a cardiac patient’s physical, psychological,
and social functioning, in addition to stabilizing,
slowing or even reversing the progression of the
4. Goals of Cardiac
Rehabilitation;
Reduction of Cardiac risk factors
Exercise & activity guidelines
Patient education
To improve functional capacity
To alleviate or lessen activity-related
symptoms
To reduce disability
To identify and modify coronary risk factors.
6. Phases of Cardiac
Rehabilitation;
Phase I : Inpatient
Phase II : Immediate Outpatient
Phase III : Intermediate Outpatient
Phase IV : Maintenance Phase of
Indefinite Length
7. Phase I;
Objectives;
Conditioning from acute event/
post-CABG
To make patient functionally
independent
To adjust with discharge from the
hospital
Psychological counselling
Nutritional counselling
8. Phase I;
Phase I relates to the period of hospitalization following
an acute cardiac event. The duration of this phase may
vary depending on the initial diagnosis, the severity of
the event and individual institutions, usually one week
acute event/post-operative.
During this phase, early mobilization and adequate
discharge planning.
Individuals typically undergo a risk factor assessment
and risk stratification
Receiving information regarding their diagnosis, risk
factors, medications and work/ social issues.
Involvement and support of the partner and family is
facilitated and encouraged.
9. Phase II;
Objectives;
Functional goals - Exercise training under
supervision/ at home
Psychosocial goals
Anxiety/depression management
Secondary preventive targets
10. Phase II;
Phase II: This phase encompasses the immediate
post discharge period, which is typically a period
of four to six weeks.
It focuses on health education and resumption of
physical activity, however the structure of this
phase may vary dramatically from centre to centre.
It may take the format of telephone follow up,
home visits, or individual or group education
sessions.
Either way, some form of contact is maintained
with the patient, facilitating ongoing education and
exchange of information.
11. Phase III;
Objectives;
Functional goals - Exercise training
under supervision
Psychosocial goals -
Return to work Return to hobbies and
lifestyle
Anxiety/depression management
Secondary preventive targets.
12. Phase III:
This phase is sometimes erroneously
referred to as the ‘Exercise’ phase.
It incorporates
Exercise training in combination with
ongoing education and psychosocial and
vocational interventions.
The duration of Phase 3 may vary from six
to 12 weeks, with patients required to
attend a CR unit two to three times weekly
for structured exercise and other lifestyle
interventions.
13. Phase IV;
Objectives;
Functional goals - Exercise training
Psychosocial goals –
Return to work
Return to hobbies and lifestyle
Anxiety/depression management
Secondary preventive targets
14. Phase IV:
This phase constitutes the components of long-
term maintenance of lifestyle changes and
professional monitoring of clinical status.
It is when patients leave the structured Phase 3
programme and continue exercise and other
lifestyle modifications indefinitely.
This may be facilitated in the CR unit itself or in a
local leisure centre.
Alternatively, individuals may prefer to exercise
independently and
Phase 4 may involve helping them set a safe and
realistic maintenance programme.
15. Benefits of Cardiac
Rehabilitation;
Reduces cardiovascular and total mortality
Does not increase non-fatal re-infarction rate
Improves myocardial perfusion
May reduce progression of atherosclerosis when
combined with aggressive diet
No consistent effects on hemodynamic, LV function or
visible collaterals
No consistent effects on cardiac arrhythmias
Improves exercise tolerance without significant CV
complications
Improves skeletal muscle strength and endurance in
clinically stable patients
Promotes favourable exercise habits
Decreases angina and CHF symptoms
16. Outcomes in Cardiac
Rehabilitation;
Smoking cessation
Lipid management
Weight control
Blood pressure control
Improved exercise
tolerance
Symptom control
Return to work
Psychological well-
being/stress
management
Physical activity
Improves glucose
metabolism
Reduces body fat
Lowers blood pressure
Improves
musculoskeletal strength
Controls body weight
Reduces symptoms of
depression
17. Assessment before exercise
training;
Clinical risk stratification is suitable for low
to moderate risk patients undergoing low
to moderate intensity exercise.
Exercise testing and echocardiography
are recommended for high risk patients
and/or high intensity exercise
Functional exercise capacity should be
evaluated before and on completion of
exercise testing.
18. Contra-indications exercise
training;
Absolute Acute myocardial infarction (within two days)
Unstable angina
Uncontrolled cardiac arrhythmias causing symptoms or
homodynamic compromise
Symptomatic severe aortic stenosis
Uncontrolled symptomatic heart failure
Acute pulmonary embolus or pulmonary infarction
Acute myocarditis or pericarditis
Active endocarditis
Acute aortic dissection
Acute noncardiac disorder that may affect exercise
performance or be aggravated by exercise
Inability to obtain consent
19. Contra-indications exercise
training;
Left main coronary stenosis or its equivalent
Moderate stenotic valvular heart disease
Electrolyte abnormalities
Severe hypertension (systolic 200 mmHg and/or
diastolic 110 mmHg)
Tachy-arrhythmias or brady-arrhythmias, including
atrial fibrillation with uncontrolled ventricular rate
Hypertrophic cardio myopathy and other forms of
outflow tract obstruction
Mental or physical impairment leading to inability to
cooperate
High-degree atrio-ventricular block
21. Exercise guidelines for Cardiac
Patient;
General In-patient Guidelines;
Frequency
Early mobilization: 3-4 times/day (days 1-3)
Later mobilization: 2 times/day (beginning on day 4)
Progression: Initially increase duration up to 10-15 min,
then increase intensity.
By hospital discharge, the patient should: Demonstrate a
knowledge of inappropriate exercises
Have a safe, progressive plan of exercise formulated for
them to take home
Selected moderate to high risk patients should be
encouraged to participate in outpatient cardiac
rehabilitation programs &/or
Manage their discharge rehabilitation plan and report any
cardiovascular symptoms promptly (should they occur).
22. General Out-patient
Guidelines;
Goals are to: Develop and help the patient to
establish and implement a safe and effective
home exercise program and recreational lifestyle,
Provide patient and family education and
therapies to maximize secondary prevention.
In general, patients should engage in multiple
activities to promote total conditioning including
aerobic and resistance exercises.
Principles of prescription are those for healthy
adults but adjusted to take into account the
patients clinical status.
23. Independent Exercise
Guidelines;
Appropriate hemodynamic response to
exercise
Appropriate ECG response
Adequate management of risk factor
intervention strategy and safe exercise
participation
Demonstrated knowledge of disease
process, abnormal signs and symptoms,
medication use and side effects.
24. Sharing the Story of the Cardiac
Rehab Patient Experience;
Ellis, Jordan M. MA; Freeman, John Taylor MA;
Midgette, Emily P. BA; Sanghvi, Anup P.; Sarathy,
Brinda; Johnson, Colin G.; Greenway, Stacey B.
MA; Whited, Matthew C. PhD
Author InformationJournal of Cardiopulmonary
Rehabilitation and Prevention: July 2019 - Volume
39 - Issue 4
Purpose:
To provide a prototypical patient narrative of
the cardiac rehabilitation (CR) experience for
providers and prospective patients using narrative
analysis.
25. Cont….
Methods:
Qualitative interviews with 17 CR patients from a previous study
regarding their experiences, reasons, and motivations related to
engagement in CR were analyzed using narrative inquiry.
Interviews were previously analyzed and coded for recurring
themes, and these themes were implemented in an exploratory
narrative inquiry to craft a CR patient “story.” A hypothetical
composite character representing the varied experiences of CR
patients interviewed was developed, and a patient story was
constructed that reflected on an initial cardiac event, time during
rehabilitation, difficult experiences, social interactions, and
personal values and accomplishments.
Results:
The CR patient narrative is presented for use in CR recruitment
and programming materials, and in provider education.
Conclusion:
The narrative analysis comprehensively provides patients with an
amalgam of patient experiences and can be used by providers to
gain an understanding of CR patient experiences. Further
research is needed to determine whether use of the
resulting narrative analysis within the referral process and/or
26. Journal Article related to Cardiac
Rehabilitation;
Muscular Strength and Cardiovascular Disease; An
updated state-of-the-art narrative review
Carbone, Salvatore PhD; Kirkman, Danielle L. PhD;
Garten, Ryan S. PhD; Rodriguez-Miguelez, Paula
PhD; Artero, Enrique G. PhD; Lee, Duck-chul PhD;
Lavie, Carl J. MD
Journal of Cardiopulmonary Rehabilitation and
Prevention: September 2020 - Volume 40 - Issue 5 -
p 302-309
This review discusses the associations of muscular
strength (MusS) with cardiovascular disease (CVD),
CVD-related death, and all-cause mortality, as well
as CVD risk factors, such as metabolic syndrome,
diabetes, obesity, and hypertension. We then briefly
27. Cont….
MusS is a strong modifiable risk factor for several CVDs,
but also CVD-related mortality and all-cause mortality.
Except for the risk of HTN, where the evidence is
conflicting, MusS seems to exert protective effects on
several CV and metabolic conditions (ie, MetS, T2DM, and
obesity). Importantly, such effects seem to be, for the most
part, independent of the amount of LM, CRF, and physical
activity. The studies discussed herein, however, cannot
prove whether dynapenia is a mediator or perhaps only a
marker of overall worse nutritional status able to identify
those with frailty and sarcopenia among others, which, in
turn, confer a greater risk for cardiometabolic diseases. In
other words, is this relationship causal or merely
association? Further study is clearly warranted to
determine whether therapeutics, including targeting
nutrition and RT, aimed at increasing MusS, with and
without changes in LM, can, in fact, affect major clinical